By Bhanvi Satija LONDON (Reuters) -German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 ...

"I began running again, and it helped me reclaim my independence and gave me back a sense of achievement that cancer ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...

When Angelina Reardon went in for a routine scan in 2021, she never imagined her life was about to change forever. What ...

Europe's health regulator has recommended the approval of GSK's cancer treatment Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy, the ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway Company on ...

Lobular breast cancer accounts for more than 10% of all breast cancer cases in the U.S., and incidence rates have increased ...